4/A: QuidelOrtho Director Edward L. Michael Amends Form 4 to Include RSU Grants

Director Edward L. Michael amends his Form 4 filing to include the grant of Converted and Premium Restricted Stock Units (RSUs) received in lieu of cash payments for board service-related fees.

Summary

• Edward L. Michael, a director of QuidelOrtho Corp, amended his Form 4 filing on August 12, 2024, to include the grant of Restricted Stock Units (RSUs) received on May 22, 2024.
• The amendment includes both 'Converted' and 'Premium' RSUs.
• 2,230 Converted RSUs and 669 Premium RSUs were granted.
• These RSUs were received in lieu of cash payments for retainer and Board of Director service-related fees under a deferred compensation program.
• 557 shares of the Converted RSUs vested on May 22, 2024, with subsequent vesting dates on August 22, 2024, November 11, 2024, and February 22, 2025.
• The Premium RSUs vest on May 22, 2025.
• Each RSU represents the right to receive one share of QuidelOrtho Corporation common stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. It reflects standard compensation practices and aligns director interests with shareholders. There are no indications of negative news or concerns.

Positives

• The director's holdings are aligned with the company's performance through stock-based compensation.
• The vesting schedule of the RSUs incentivizes continued service on the board.

Future Outlook

The document does not contain specific forward-looking statements beyond the RSU vesting schedule.

Industry Context

Stock-based compensation is a common practice for directors of publicly traded companies to align their interests with those of shareholders.

Comparison to Industry Standards

• RSU grants are a standard form of compensation for board members in publicly traded companies, similar to practices at companies like Abbott Laboratories (ABT) and Danaher Corporation (DHR).
• The vesting schedules are typical, designed to incentivize continued service and align director interests with long-term shareholder value, comparable to vesting schedules seen in director compensation packages at Roche Holding AG (ROG.SW).

Stakeholder Impact

• Shareholders: The RSU grants align the director's interests with shareholder value.
• Employees: The grants are part of the overall compensation structure and may influence employee morale positively.
• Company: The grants help retain experienced board members.

Key Dates